** Shares of BPH Global BP8.AX rise as much as 50% to
A$0.003, set for best day since Aug 11, if gains hold
** The biotech co says it will acquire 100% of Foshan
Gedishi Biotechnology, a company that operates the birds' nest
pilot study with BP8's China Partners
** Deal to reactivate and expand co's bird nest business in
China - BPH Global
** Co anticipates that completion of the acquisition will
take place by Oct 31
** Stock at highest level since Aug 15
** BPH stock down 84.8% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))